Zoledronic acid - Study guides, Class notes & Summaries

Osteoporosis - Answer Progressive loss of bone mass. Increased risk for fractures. Type 1 occurs primarily in post menopausal women. Type 2 is men and women. Can be caused by other diseases or medications. Such as oasis, steroids, heparin, etc. osteomalacia - Answer Softening of the bone. Adults version of rickets. Low vitamin D. Can also be caused by hyperparathryoidism. Nirmal vitamin d level is 20-80. Paget Disease - Answer Disorder of bone remodeling. Typically occurs in one o...

Osteoporosis - Answer Progressive loss of bone mass. Increased risk for fractures. Type 1 occurs primarily in post menopausal women. Type 2 is men and women. Can be caused by other diseases or medications. Such as oasis, steroids, heparin, etc. osteomalacia - Answer Softening of the bone. Adults version of rickets. Low vitamin D. Can also be caused by hyperparathryoidism. Nirmal vitamin d level is 20-80. Paget Disease - Answer Disorder of bone remodeling. Typically occurs in one o...

CSO EXAM PREP Questions and answers, graded A+ A cancer patient is unable to provide self-care. His disease is progressing rapidly and prognosis is poor. Which number likely represents his Karnofsky Performance Status? A. 100 B. 70 C. 40 D. 0 - -C. 40 Disabled; requires special care & assistance. ************************************************** 0 - DEAD 100 - no evidence of disease A cancer patient is fully active and able to carry on all pre-disease activities without restrictio...

PRE-NAPLEX EXAM Questions with 100% Correct Answers How do you calculate RRR? You have these values: Zoledronic acid (risk of fracture): 8.6% Placebo (risk of fracture): 13.9% 1) Calculate the RR (% Tx/% Control) 8.6%/13.9% = 0.6187 2) Calculate RRR: (1 - RR) 1 - 0.6187 = 0.38 RRR: 38% Zoledronic Acid treated patients where 38% less likely to have a fracture than placebo treated patients. You have a case: The primary endpoint for a fracture was lower with Zoledronic acid compared ...

How do you calculate RRR? You have these values: Zoledronic acid (risk of fracture): 8.6% Placebo (risk of fracture): 13.9% 1) Calculate the RR (% Tx/% Control) 8.6%/13.9% = 0.6187 2) Calculate RRR: (1 - RR) 1 - 0.6187 = 0.38 RRR: 38% Zoledronic Acid treated patients where 38% less likely to have a fracture than placebo treated patients.

ATI Pharmacology proctored Exam Test Bank 1 A provider prescribes phenobarbital for a client who has a seizure disorder. The medication has a long half-life of 4 days. How many times per day should the nurse expect to administer this medication? A. One B. Two C. Three D. Four A staff educator is reviewing medication dosages and factors that influence medication metabolism with a group of nurses at an in-service presentation. Which of the following factors should the educator include a...

Osteoporosis - Answer Progressive loss of bone mass. Increased risk for fractures. Type 1 occurs primarily in post menopausal women. Type 2 is men and women. Can be caused by other diseases or medications. Such as oasis, steroids, heparin, etc. osteomalacia - Answer Softening of the bone. Adults version of rickets. Low vitamin D. Can also be caused by hyperparathryoidism. Nirmal vitamin d level is 20-80. Paget Disease - Answer Disorder of bone remodeling. Typically occurs in one o...

PRE-NAPLEX Exam Questions & Answers. VERIFIED How do you calculate RRR? You have these values: Zoledronic acid (risk of fracture): 8.6% Placebo (risk of fracture): 13.9% 1) Calculate the RR (% Tx/% Control) 8.6%/13.9% = 0.6187 2) Calculate RRR: (1 - RR) 1 - 0.6187 = 0.38 RRR: 38% Zoledronic Acid treated patients where 38% less likely to have a fracture than placebo treated patients. You have a case: The primary endpoint for a fracture was lower with Zoledronic acid compared to pla...

CCFP EXAM 2024 VERIFIED TO SCORE A+